Preliminary study of TIP47 as a possible new biomarker of cervical dysplasia and invasive carcinoma

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 717-724

  Szigeti, Andras ^a   Minik, Orsolya ^a   Hocsak, Eniko ^a   Pozsgai, Eva ^a   Boronkai, Arpad ^a   Farkas, Robert ^a   Balint, Andras ^a   Bodis, Jozsef ^a   Sumegi, Balazs ^a   Bellyei, Szabolcs ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cervical cytology; Neoplasm metastasis; TIP47; Tumor marker; Uterine cervical neoplasm

Indexed keywords

BIOLOGICAL MARKER; MEMBRANE PROTEIN; PROTEIN TIP47; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERUS CARCINOMA;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOPLASM; DNA-BINDING PROTEINS; FEMALE; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NIH 3T3 CELLS; PREGNANCY PROTEINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 61449239343     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Yang SF, Yuan SS, Yeh YT, Wu MT, Su JH, Hung SC and Chai CY: The role of p-stat3 (ser727) revealed by its association with Ki-67 in cervical intraepithelial neoplasia. Gynecol Oncol 98(3): 446-452, 2005.
2. INK4a and prb expression in cervical squamous and glandular neoplasia. Hum Pathol 35(6): 689-696, 2004.
3. INK4a expression in cervical premalignant and malignant lesions. Exp Mol Pathol 80(2): 192-196, 2006.
4. Nam EJ, Kim JW, Kim SW, Kim YT, Kim JH, Yoon BS, Cho NH and Kim S: The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol Oncol 104(1): 207-211, 2007.
5. Barbero P, Buell E, Zulley S and Pfeffer SR: TIP47 is not a component of lipid droplets. J Biol Chem 276(26): 24348-24351, 2001.
6. Diaz E and Pfeffer SR: TIP47: A cargo selection device for mannose 6-phosphate receptor trafficking. Cell 93(3): 433-443, 1998.
7. Hickenbottom SJ, Kimmel AR, Londos C and Hurley JH: Structure of a lipid droplet protein: the PAT family member TIP47. Structure 12(7): 1199-1207, 2004.
8. McManaman JL, Zabaronick W, Schaack J and Orlicky DJ: Lipid droplet targeting domains of adipophilin. J Lipid Res 44(4): 668-673, 2003.
9. Wolins NE, Rubin D and Brasaemle DL: TIP47 associates with lipid droplets. J Biol Chem 276(7): 5101-5108, 2001.
10. Than NG, Sumegi B, Than GN, Kispal G and Bohn H: Cloning and sequence analysis of cDNAs encoding human placental tissue protein 17 (PP17) variants. Eur J Biochem 258(2): 752-757, 1998.
11. Than NG, Sumegi B, Than GN, Kispal G and Bohn H: Is placental tissue protein 17b/TIP47 a new factor in cervical cancer genesis? Anticancer Res 19(6B): 5255-5258, 1999.
12. Krise JP, Sincock PM, Orsel JG and Pfeffer SR: Quantitative analysis of TIP47-receptor cytoplasmic domain interactions - implications for endosome-to-trans golgi network trafficking. J Biol Chem 275(33): 25188-25193, 2000.
13. Orsel JG, Sincock PM, Krise JP and Pfeffer SR: Recognition of the 300-kDa mannose 6-phosphate receptor cytoplasmic domain by 47-kDa tail-interacting protein. Proc Natl Acad Sci USA 97(16): 9047-9051, 2000.
14. Carroll KS, Hanna J, Simon I, Krise J, Barbero P and Pfeffer SR: Role of rab9 GTPase in facilitating receptor recruitment by TIP47. Science 292(5520): 1373-1376, 2001.
15. Hanna J, Carroll K and Pfeffer SR: Identification of residues in TIP47 essential for Rab9 binding. Proc Natl Acad Sci USA 99(11): 7450-7454, 2001.
16. Ganley IG, Carroll K, Bittova L and Pfeffer S: Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. Mol Biol Cell 15(12): 5420-5430, 2004.
17. Than NG, Sumegi B, Bellyei S, Berki T, Szekeres G, Janaky T, Szigeti A, Bohn H and Than GN: Lipid droplet and milk lipid globule membrane-associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical carcinoma cells. Eur J Biochem 270(6): 1176-1188, 2003.
18. Than GN, Turoczy T, Sumegi B, Than NG, Bellyei S, Bohn H, and Szekeres G: Overexpression of placental tissue protein 17b/TIP47 in cervical dysplasias and cervical carcinoma. Anticancer Res 21(1B): 639-642, 2001.
19. Than NG, Sumegi B, Than GN, Kispal G and Bohn H: Cloning and sequencing of human oncodevelopmental soluble placental tissue protein 17 (PP17): homology with adipophilin and the mouse adipose differentiation-related protein. Tumor Biol 20(4): 184-192, 1999.
20. Abe Y, Kimura K, Horiuchi A, Miyake M and Kimura S: Improvement of ELISA sensitivity by allogeneric adsorption of polyclonal antibodies - a technical note for non-experts. Clin Chim Acta 224(1): 103-105, 1994.
21. Tapodi A, Debreceni B, Hanto K, Bognar Z, Wittmann I, Gallyas F, Varbiro G and Sumegi B: Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose) polymerase-1 inhibition in oxidative stress. J Biol Chem 280(42): 35767-35775, 2005.
22. Liu SS, Tsang BK, Cheung ANY, Xue WC, Cheng DKL, Ng TY, Wong LC and Ngan HYS: Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 37(9): 1104-1110, 2001.
23. Nam JH, Chang KC, Chambers JT, Schwartz PE and Cole LA: Urinary gonadotropin fragment, a new tumor-marker use in cervical and vulvar cancers. Gynecol Oncol 38(1): 66-70, 1990.
24. Ngan HYS, Cheng GTS, Yeung WSB, Wong LC and Ma HK: The prognostic value of Tpa and Scc in squamous-cell carcinoma of the cervix. Gynecol Oncol 52(7): 63-68, 1994.
25. INK4a expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 97(1): 35-40, 2005.
26. INK4a expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Path Res Pract 202(2): 77-83, 2006.
27. Ackerman WE, Robinson JM and Kniss DA: Association of PAT proteins with lipid storage droplets in term fetal membranes. Placenta 28(5-6): 465-476, 2007.
28. Ohsaki Y, Maeda T, Maeda M, Tauchi-Sato K and Fujimoto T: Recruitment of TIP47 to lipid droplets is controlled by the putative hydrophobic cleft. Biochem Biophys Res Comm 347(1): 279-287, 2006.
29. Robenek H, Lorkowski S, Schnoor M and Troyer D: Spatial integration of TIP47 and adipophilin in macrophage lipid bodies. J Biol Chem 280(7): 5789-5794, 2005.
30. Sztalryd C, Bell M, Lu XY, Mertz P, Hickenbottom S, Chang BHJ, Chan L, Kimmel AR and Londos C: Functional compensation for adipose differentiation- related protein (ADFP) by Tip47 in an ADFP null embryonic cell line. J Biol Chem 281(45): 34341-34348, 2006.
31. Mathur SP, Mathur RS, Underwood PB, Kohler MF and Creasman WT: Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol 91(3): 486-493, 2003.
32. Catrina SB, Lewitt M, Massambu C, Dricu A, Grunler J, Axelson M, Biberfeld P and Brismar K: Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival. Br J Cancer 92(8): 1467-1474, 2005.
33. Mathur RS and Mathur SP: Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Gynecol Oncol 97(1): 206-213, 2005.
34. Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M and Creasman WT: Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: relationship to insulin-like growth factor II (IGF-II), IGF-binding protein 3 (IGF-BP3) and VEGF-A [Corrected]. Gynecol Oncol 98(3): 467-483, 2005.
35. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K and Sekiya S: Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 103(4): 724-730, 2005.
36. Strauss HG, Laban C, Lautenschager C, Buchmann J, Schneider I and Koelbl H: SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix. Eur J Cancer 38(15): 1987-1991, 2002.